Clinical trial Recruiting at 2 sites Observational Ages 18 to 75

Exploring stigma and psychological profiles in rectal and anal cancer patients

Official title: Stigma and Psychological profilE in REctal-anal caNcer pAtients

Run by Fondazione Policlinico Universitario Agostino Gemelli IRCCS · NCT06366841 · Data updated 2026-11-12

This study looks at the feelings and challenges faced by patients with rectal and anal cancer during long-term treatment to see how these issues affect their mental health and well-being.

More Rectal Cancer trials

Quick facts

Study typeObservational
Ages18 Years to 75 Years
SexAll
Enrollment148 (estimated)
SponsorFondazione Policlinico Universitario Agostino Gemelli IRCCS
Academic / other
Drugs / interventionsradiation
Locations2 sites (Roma and 1 other locations)
StatusRecruiting
StartedMay 6, 2024
Main results expectedOctober 31, 2027
Study endsJuly 1, 2028
Registry record updatedOctober 14, 2026
Trial IDNCT06366841 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are adults aged 18 years and older with locally advanced rectal or anal cancer undergoing long-course radiotherapy.

Probably not a fit

Patients over 75 years old or those undergoing short-course or palliative radiotherapy may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This observational study focuses on patients with locally advanced rectal and anal cancer who are undergoing long-term radiotherapy. It aims to investigate the psychological distress and stigma associated with these conditions, examining factors such as temperament, personality, and alexithymia. By administering psychological tests, the study seeks to understand the broader psychosocial impacts of rectal cancer beyond physical symptoms. The findings could provide insights into the unique challenges faced by these patients and inform supportive care strategies.

Why it matters

Potential benefit: If successful, this study could enhance understanding of the psychological needs of rectal and anal cancer patients, leading to improved support and interventions.

How similar studies have gone: While the specific focus on stigma and psychological profiling in this context may be novel, related studies have shown the importance of addressing psychosocial factors in cancer care.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

Locally advanced rectal and anal cancer patients undergoing a long course of radiotherapy

* Patients in chemo-radiation treatment
* Ability to understand and complete the questionnaires
* Age ≥18 years
* Informed consent signed

Exclusion Criteria:

* Age \> 75 years
* Rectal and anal cancer patients undergoing short-course radiotherapy
* Rectal and anal cancer patients undergoing palliative radiotherapy
* Patients with inability to express informed consent
* Patients denying informed consent
* Patients with psychopathological disturbances preexisting to the cancer diagnosis
* Patients affected by severe language deficits

Where it's running

  • Fondazione Policlinico Universitario A. Gemelli IRCCS - Psychology service
    Roma, Italy
    Recruiting
  • Fondazione Policlinico Universitario A. Gemelli IRCCS
    Roma, Italy
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

  • Virtual exercise program to preserve function and prevent disability during chemotherapy

    This trial tests whether supervised resistance sessions by video plus short home aerobic workouts help adults 18–64 maintain strength and stay active while receiving curative-intent chemotherapy.

    Recruiting at 29 sites Alliance for Clinical Trials in Oncology · Dublin, California and 29 other locations · NCT07059884

  • Improving care for Black patients with gastrointestinal cancer

    This study is trying to improve cancer care for Black patients with gastrointestinal cancers by ensuring they get the right tests and treatments while helping us understand the challenges they face.

    Recruiting Case Comprehensive Cancer Center · Cleveland, Ohio · NCT06263088

  • Using virtual reality to help manage pain in GI cancer patients

    This study is testing if virtual reality can help people with GI cancer manage their severe abdominal pain better than standard treatments.

    Recruiting Cedars-Sinai Medical Center · Los Angeles, California · NCT04907643

  • A resource for collecting cancer data and biospecimens

    This study is creating a resource to collect health information and samples from cancer patients and healthy individuals to help improve cancer prevention and treatment strategies.

    Recruiting at 42 sites University of Nebraska · Greenwood Village, Colorado and 41 other locations · NCT02012699

  • Single vs. double stapling and purse-string techniques after rectal cancer surgery

    This trial tests whether using a single-stapling method to join the bowel after rectal cancer surgery results in fewer leaks compared with the double-stapling method.

    Recruiting Alexandria University · Alexandria · NCT07929415

  • Retifanlimab after chemoradiation for anal cancer

    This study tests whether retifanlimab can help people with anal squamous cell carcinoma who have completed chemoradiation and still have residual disease.

    Recruiting at 7 sites Phase 2 Memorial Sloan Kettering Cancer Center · Basking Ridge, New Jersey and 6 other locations · NCT07927998

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.